Form 4 filings across 2 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$84.4K
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 5 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 10 most recent Form 4 transactions.
| Jun 10 | QURE | uniQure N.V. | AGRANT | 7,550 | — | — | +26.6% | Open the original filing on SEC.gov |
| May 19 | CRBP | Corbus Pharmaceuticals… | AGRANT◆ | 12,300 | — | — | — | Open the original filing on SEC.gov |
| May 19 | CRBP | Corbus Pharmaceuticals… | AGRANT | 3,800 | — | — | +50.1% | Open the original filing on SEC.gov |
| Jun 20, 2025 | QURE | uniQure N.V. | SSELL | 2,112 | $14.45 | $30.5K | -6.9% | Open the original filing on SEC.gov |
| Jun 11, 2025 | QURE | uniQure N.V. | AGRANT◆ | 15,630 | — | — | — | Open the original filing on SEC.gov |
| Jun 11, 2025 | QURE | uniQure N.V. | AGRANT | 7,970 | — | — | +35.4% | Open the original filing on SEC.gov |
| May 30, 2025 | CRBP | Corbus Pharmaceuticals… | AGRANT◆ | 16,000 | — | — | — | Open the original filing on SEC.gov |
| May 30, 2025 | CRBP | Corbus Pharmaceuticals… | AGRANT | 4,800 | — | — | +172.5% | Open the original filing on SEC.gov |